Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 9Neoplasms 5Endometrial Neoplasms 3Prostatic Neoplasms 2Peripheral Nervous System Diseases 2Obesity 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Leukemia, Myeloid, Acute 2Leiomyoma 2Insulin Resistance 2Inflammation 2Infertility, Female 2Glioblastoma 2Diabetes Mellitus 2Colorectal Neoplasms 2Cognitive Dysfunction 2Cardiotoxicity 2Weight Gain 1Vomiting 1Venous Thromboembolism 1Vascular Malformations 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Stem Cell Transplant Complications 1

Interventions

Inositol 2Tablets 1Sildenafil Citrate 1Metformin 1Furosemide 1Folic Acid 1Cari-D-Tect 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pre-Eclampsia × Tablets × Clear all
NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed
257 enrolled

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡